CIBC Asset Management’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,573
Closed -$99.8K 1203
2024
Q1
$99.8K Hold
10,573
﹤0.01% 1084
2023
Q4
$116K Hold
10,573
﹤0.01% 1049
2023
Q3
$67.6K Hold
10,573
﹤0.01% 1012
2023
Q2
$50.9K Hold
10,573
﹤0.01% 1063
2023
Q1
$43.6K Buy
+10,573
New +$44.9K ﹤0.01% 1037

Other funds holding THRD

CIBC Asset Management's THRD Position: Q2 2024 in Review

CIBC Asset Management sold out of Third Harmonic Bio (THRD) in Q2 2024, closing a stake of 10,573 shares — an estimated $99.8K sold.

CIBC Asset Management first reported a position in THRD in Q1 2023 and held it in 5 quarters. The position peaked at $116K in Q4 2023. 76 funds tracked by Wall St. Rank hold THRD as of Q2 2024.

  • CIBC Asset Management reported no remaining Third Harmonic Bio position as of Q2 2024 after selling out during the quarter.
  • CIBC Asset Management sold 10,573 Third Harmonic Bio shares in Q2 2024, an estimated $99.8K.
  • CIBC Asset Management first reported a position in Third Harmonic Bio in Q1 2023 and held it in 5 quarters.
  • CIBC Asset Management's Third Harmonic Bio position peaked at $116K in Q4 2023.
  • 76 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2024.

Based on CIBC Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.